Stockreport

TapImmune reports Q1 results [Seeking Alpha]

TAPIMMUNE INC COMMON  (TPIV) 
NASDAQ:AMEX Investor Relations: tapimmune.com/investors
PDF TapImmune reports Q1 resultsTapImmune (NASDAQ:TPIV): Q1 EPS of -$0.30Press ReleaseClick to subscribe to real-time analytics on TPIVNow read:Lantheus (LNTH) Presents At 2 [Read more]